Agentes indutores da síntese de hemoglobina fetal Fetal hemoglobin inducing factors

Agentes indutores da síntese de hemoglobina fetal Fetal hemoglobin inducing factors

Anemia falciforme é uma doença heterogênea caracterizada por uma grande variabilidade clínica. Desde as primeiras observações desta doença, foi visto que aumento no nível de hemoglobina fetal (HbF) estava associado com manifestações clínicas mais brandas, já que a HbF interfere na polimerização da H...

Full description

Bibliographic Details
Main Author:	Maria Stella Figueiredo
Format:	Article
Language:	English
Published:	Elsevier 2007-09-01
Series:	Revista Brasileira de Hematologia e Hemoterapia
Subjects:	Anemia falciforme hidroxiuréia síntese de HbF tratamento Sickle cell anemia hydroxyurea HbF synthesis treatment
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842007000300024

Similar Items

Fetal hemoglobin modifies the disease manifestation of severe Plasmodium falciparum malaria in adult patients with sickle cell anemia.
by: Prasanta Purohit
Published: (2016-11-01)

پاسخ بیماران مبتلا به تالاسمی اینترمدیا به درمان هیدروکسی اوره
by: Majid Motovali-Bashi, et al.
Published: (2014-02-01)

Two cases of vitamin B12 deficiency in patients with beta-thalassemia trait: lessons in diagnosis
by: Kriti Chauhan, et al.
Published: (2023-12-01)

Pharmacogenomics of sickle cell disease: steps toward personalized medicine
by: Husain M, et al.
Published: (2017-10-01)

The Role of miRNAs as Therapeutic Tools in Sickle Cell Disease
by: Cyril Cyrus
Published: (2021-10-01)

MicroRNA29B induces fetal hemoglobin via inhibition of the HBG repressor protein MYB in vitro and in humanized sickle cell mice
by: Qingqing Gu, et al.
Published: (2022-11-01)

Different Therapeutic Interventions And Mechanisms of Action of Antisickling Agents Currently in Use in Sickle Cell Disease Management
by: Ngozi Awa Imaga, et al.
Published: (2017-08-01)

Influence of Oxidative Stress Biomarkers and Genetic Polymorphisms on the Clinical Severity of Hydroxyurea-Free Senegalese Children with Sickle Cell Anemia
by: Fatou Gueye Tall, et al.
Published: (2020-09-01)

Management of ß-thalassemia – Consensus and controversies!
by: Mamta V. Manglani, et al.
Published: (2017-12-01)

Eficácia e toxicidade da hidroxiuréia em crianças com anemia falciforme Effectiveness and toxicity of hydroxyurea in children with sickle cell anemia
by: Michelle C. Silva, et al.
Published: (2006-06-01)

Chronic disease prevalence in a population with structural hemoglobin disorders undergoing diabetes diagnosis: A bayesian approach
by: Maryory Galvis, et al.
Published: (2024-01-01)

Prevalence and Impact of HMOX1 Polymorphism (rs2071746: A > T) in Indian Sickle Cell Disease Patients
by: Hareram Pandey, et al.
Published: (2023-12-01)

Introducing Negatively Charged Residues on the Surface of Fetal Hemoglobin Improves Yields in Escherichia coli
by: Karin Kettisen, et al.
Published: (2021-09-01)

HbE and HbF levels in HbE/βO-thalassemia are heterogeneous
by: Thanusak Tatu, et al.
Published: (2011-01-01)

Erythroid Adhesion Molecules in Sickle Cell Anaemia Infants: Insights Into Early Pathophysiology
by: Valentine Brousse, et al.
Published: (2015-02-01)

miRNA Expression Associated with HbF in Saudi Sickle Cell Anemia
by: Cyril Cyrus, et al.
Published: (2022-10-01)

Unique Polymorphisms at <i>BCL11A</i>, <i>HBS1L-MYB</i> and <i>HBB</i> Loci Associated with HbF in Kuwaiti Patients with Sickle Cell Disease
by: Nagihan Akbulut-Jeradi, et al.
Published: (2021-06-01)

Induction of Fetal Hemoglobin by Introducing Natural Hereditary Persistence of Fetal Hemoglobin Mutations in the γ-Globin Gene Promoters for Genome Editing Therapies for β-Thalassemia
by: Dian Lu, et al.
Published: (2022-05-01)

Combined approaches for increasing fetal hemoglobin (HbF) and de novo production of adult hemoglobin (HbA) in erythroid cells from β-thalassemia patients: treatment with HbF inducers and CRISPR-Cas9 based genome editing
by: Alessia Finotti, et al.
Published: (2023-07-01)

Methemoglobin measure in adult patients with sickle-cell anemia: influence of hydroxyurea therapy
by: Marilia Rocha Laurentino, et al.
Published: (2014-06-01)

Induction of HBF
by: Mehran Karimi, et al.
Published: (2013-03-01)

The role of OMICS research in understanding phenotype variation in thalassaemia: the THALAMOSS project
by: Roberto Gambari
Published: (2014-12-01)

Manifestações retinianas em pacientes portadores de anemia de células falciformes
by: Edmundo Frota de Almeida Sobrinho, et al.
Published: (2011-10-01)

Treatment of Erythroid Precursor Cells from β-Thalassemia Patients with <i>Cinchona</i> Alkaloids: Induction of Fetal Hemoglobin Production
by: Cristina Zuccato, et al.
Published: (2021-12-01)

Avaliação de prescrições pediátricas de hidroxiureia para pacientes com doença falciforme
by: Fernanda Alice Tanimoto Duque, et al.
Published: (2022-11-01)

The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34<sup>+</sup> Cells from Sickle Cell Disease Patients
by: Ekati Drakopoulou, et al.
Published: (2022-12-01)

Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea
by: Vasiliki Chondrou, et al.
Published: (2018-10-01)

Identification and Functional Analysis of Known and New Mutations in the Transcription Factor KLF1 Linked with β-Thalassemia-like Phenotypes
by: Rosa Catapano, et al.
Published: (2023-03-01)

Estudo da correlação entre os níveis de hemoglobina fetal e o prognóstico dos pacientes com anemia falciforme Study of the correlation between fetal hemoglobin levels and the prognosis of patients with sickle cell anemia
by: Lilianne B. Silva, et al.
Published: (2009-01-01)

Using Clustered Regularly Interspaced Short Palindromic Repeats gene editing to induce permanent expression of fetal hemoglobin in β-thalassemia and sickle cell disease: A comparative meta-analysis
by: Anthony Quagliano, et al.
Published: (2022-09-01)

Closed relationship of βE-allele and high HbF associated cis-loci: Case studies in Thai HbE/ β-thalassemia families
by: Lamplimas Tangpan, et al.
Published: (2015-05-01)

Prevalência de hemoglobinas anormais em recém-nascidos da cidade de Natal, Rio Grande do Norte, Brasil Prevalence of abnormal hemoglobins in newborns in Natal, Rio Grande do Norte, Brazil
by: Maria Cristina Pignataro Emerenciano de Araújo, et al.
Published: (2004-02-01)

Prevalência de hemoglobina S em recém-nascidos de Fortaleza: importância da investigação neonatal The prevalence of hemoglobin S in newborns from Fortaleza, Brazil: the importance of neonatal research
by: Luciano Silveira Pinheiro, et al.
Published: (2006-02-01)

In Vitro and In Vivo Studies for the Investigation of γ-Globin Gene Induction by Adhatoda vasica: A Pre-Clinical Study of HbF Inducers for β-Thalassemia
by: Fizza Iftikhar, et al.
Published: (2022-03-01)

Cytotoxicity and DNA damage in the neutrophils of patients with sickle cell anaemia treated with hydroxyurea
by: Alano Martins Pedrosa, et al.
Published: (2014-04-01)

Prevalência da hemoglobina S no Estado do Paraná, Brasil, obtida pela triagem neonatal Prevalence of hemoglobin S in the State of Paraná, Brazil, based on neonatal screening
by: Alexandra M. Watanabe, et al.
Published: (2008-05-01)

Molecular Detection of Hemoglobin O-Arab in the Sudanese Population
by: Elbashir I, et al.
Published: (2023-08-01)

Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
by: Emanuel Almeida Moreira de Oliveira, et al.

Protocolo clínico e diretrizes terapêuticas para uso de hidroxiureia na doença falciforme Clinical protocol and therapeutic guidelines for the use of hydroxyurea in sickle cell disease
by: Rodolfo D. Cançado, et al.
Published: (2009-01-01)

Periferik Kanında %100 HbF Bulunan Talasemi İntermedia Olgusu
by: Ayşegül Uğur Kurtoğlu, et al.
Published: (2021-06-01)